The role of CD40L (gp39)/CD40 in T/B cell interaction and primary immunodeficiency
- 31 December 1994
- journal article
- Published by Elsevier in Research in Immunology
- Vol. 145 (3) , 210-215
- https://doi.org/10.1016/s0923-2494(94)80186-x
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bcl‐2 inductionEuropean Journal of Immunology, 1993
- Activated B cells from patients with common variable immunodeficiency proliferate and synthesize immunoglobulin.Journal of Clinical Investigation, 1993
- The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndromeCell, 1993
- Molecular analysis of the induction of immunoglobulin E synthesis in human B cells by interleukin 4 and engagement of CD40 antigen.The Journal of Experimental Medicine, 1992
- Clinical and immunologic analyses of 103 patients with common variable immunodeficiencyJournal of Clinical Immunology, 1989
- Synergistic interaction between interleukin 4 and anti-Bp50 (CDw40) revealed in a novel B cell restimulation assayEuropean Journal of Immunology, 1987
- Evidence for a Defect in Switch T Cells in Patients with Immunodeficiency and Hyperimmunoglobulinemia MNew England Journal of Medicine, 1986
- Polyclonal immunoglobulin secretion in patients with common variable immunodeficiency using monoclonal B cell differentiation factors.Journal of Clinical Investigation, 1984
- Hyper Immunoglobulin M Immunodeficiency (Dysgammaglobulinemia)Journal of Clinical Investigation, 1979
- Immunologic responses to bacteriophage ϕX 174 in immunodeficiency diseasesJournal of Clinical Investigation, 1971